# Fellow Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/fellow-health

- Industry: Healthcare
- Headquarters: San Leandro, US
- Website: www.meetfellow.com
- Total disclosed funding: $24M
- Latest round: Series B (Jul 15, 2025)
- Investors on record: 2

## About

Based in the US, Fellow Health, Inc. operates in the fertility testing sector, specializing in user-friendly, mail-in semen analysis services that enhance patient compliance and convenience.Fellow Health, Inc. provides innovative mail-in semen analysis services to improve fertility testing experiences for patients. Founded in 2018 and headquartered in San Francisco, US, the company has raised a total of USD 24.00 mn through its Series B funding round on July 15, 2025, led by 5AM Ventures with participation from The Forest Road Company. The founder's history is not publicly detailed, and there is no mention of any changes in business operations or subsidiary relationships.Fellow specializes in providing peer-reviewed, mail-in semen analysis services aimed at improving patient compliance and offering a user-friendly solution for fertility testing. Their core product is the mail-in semen analysis kit, which allows patients to provide samples from the privacy of their homes, ensuring convenience and comfort. The company's CLIA-certified diagnostics lab processes these samples, delivering clinically valid results within two business days of receipt. Fellow's services enhance the testing experience for patients and support clinics in increasing their compliance rates, achieving up to 97% compared to traditional in-office testing methods, which typically see compliance rates around 50%. The primary clients of Fellow include over 1,500 clinics across the United States, serving both urologists and fertility specialists, thereby reaching a diverse patient demographic seeking fertility evaluations.Fellow generates revenue through B2B partnerships with clinics and direct-to-consumer sales of their semen analysis kits. Their business model focuses on providing a streamlined and efficient testing process, facilitating transactions primarily through direct sales to medical practices that utilize their services for patient testing. The pricing structure caters to both individual patients and healthcare providers, allowing for bulk purchases by clinics seeking to enhance their service offerings. Fellow's flagship service, the mail-in semen analysis, is complemented by additional offerings such as cryopreservation services, which provide patients with the option to secure their fertility after analysis. This structured service delivery ensures timely results and effective communication between Fellow, clinics, and patients, establishing a reliable ecosystem for fertility testing and management.In July 2025, Fellow Health, Inc. raised USD 24 million in Series B funding, which will be used to expand mail-in semen analysis services and increase clinical partner network coverage. The company aims to enhance access initiatives, including employer-sponsored fertility benefits. Specific plans for geographic expansion and product launches are in development, reflecting the company's commitment to growing its reach and improving fertility testing solutions.

## Funding rounds

- Series B, Jul 15, 2025, $24M — 5AM Ventures, Forest Road Company

## Investors

- 5AM Ventures (https://capitalatlas.ai/funds/5am-ventures) — Series B
- Forest Road Company (https://capitalatlas.ai/funds/forest-road-company) — Series B